Comparing Tirzepatide with Carbohydrate Counting for type 1 diabetes
Explore this study →
There are 2 groups in this study. Group A receives Tirzepatide, together with one or more of: Tandem Control-IQ Automated Insulin Delivery System (with Dexcom G7 CGM), Carbohydrate Counting and No Meal Announcement. Group B, the comparison group, receives one or more of: Tandem Control-IQ Automated Insulin Delivery System (with Dexcom G7 CGM) and Carbohydrate Counting.
3 sites in Montreal
- Phase 2
- 2 groups
- 3 sites in Montreal
- Recruiting
Official title: A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
Type 1 Diabetes · McGill University Health Centre/Research Institute of the McGill University Health Centre